A phase 1 trial of APG-1387, an IAP antagonist, with nab-paclitaxel and gemcitabine in patients with refractory metastatic pancreatic cancer
一项针对难治性转移性胰腺癌患者的 I 期临床试验,评估 IAP 拮抗剂 APG-1387 联合白蛋白紫杉醇和吉西他滨的疗效
期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2025.102364
Shi, Si; Zhang, Jian; Liu, Rujiao; Gao, Shuiping; Xu, Jin; Wang, Wei; Wei, Miaoyan; Li, Jialin; Liu, Chen; Xu, Xiaowu; Pan, Wentao; Tian, Xiaohong; Men, Lichuang; Wang, Hengbang; Liang, Zhiyan; Zhu, Min; Yang, Dajun; Zhai, Yifan; Yu, XianJun